Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S5YC
|
||||
| Former ID |
DNC013581
|
||||
| Drug Name |
MEPTAZINOL
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Approved | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H24ClNO
|
||||
| Canonical SMILES |
CCC1(CCCCN(C1)C)C2=CC(=CC=C2)O
|
||||
| InChI |
1S/C15H23NO/c1-3-15(9-4-5-10-16(2)12-15)13-7-6-8-14(17)11-13/h6-8,11,17H,3-5,9-10,12H2,1-2H3
|
||||
| InChIKey |
JLICHNCFTLFZJN-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 54340-58-8
|
||||
| PubChem Compound ID | |||||
| SuperDrug ATC ID |
N02AX05
|
||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [2] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| WikiPathways | Irinotecan Pathway | ||||
| References | |||||
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
| REF 2 | J Med Chem. 2008 Apr 10;51(7):2027-36. Epub 2008 Mar 12.Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.